Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Shareholders' Equity

v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023 $ 302,182 $ 19,881 $ 3,718 $ (250,911) $ 74,870
Beginning Balance (in shares) at Dec. 31, 2023 270,898,900        
Shares issued for cash $ 97,568       97,568
Shares issued for cash (in shares) 82,662,325        
Share issue costs $ (4,683)       (4,683)
Exercise of warrants $ 15,849       15,849
Exercise of warrants (in shares) 8,188,250        
Exercise of stock options $ 2,326 (319)     $ 2,007
Exercise of stock options (in shares) 2,351,563       2,351,563
Stock option liability adjustment   (1,310)     $ (1,310)
Redemption of RSUs   (60)     (60)
Stock compensation   1,276     1,276
Net income (loss)     471 (53,189) (52,718)
Ending Balance at Dec. 31, 2024 $ 413,242 19,468 4,189 (304,100) 132,799
Ending Balance (in shares) at Dec. 31, 2024 364,101,038        
Shares issued for cash $ 15,983       15,983
Shares issued for cash (in shares) 10,619,331        
Share issue costs $ (399)       (399)
Exercise of warrants $ 730       730
Exercise of warrants (in shares) 383,750        
Exercise of stock options $ 2,567 (12)     $ 2,555
Exercise of stock options (in shares) 2,568,097       2,568,097
Redemption of RSUs $ 638 (747)     $ (109)
Redemption of RSUs (in shares) 497,493        
Stock compensation   936     936
Net income (loss)     (145) (74,898) (75,043)
Ending Balance at Dec. 31, 2025 $ 432,761 $ 19,645 $ 4,044 $ (378,998) $ 77,452
Ending Balance (in shares) at Dec. 31, 2025 378,169,709